Reneo Pharmaceuticals Inc. (RPHM)
$1.81
$-15.49
(-89.54%)
As on 04-Oct-2024 18:32EDT
Market cap
$61 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
3,342,880
5 Years Aggregate
CFO
$-180.07 Mln
EBITDA
$-211.03 Mln
Net Profit
$-199.12 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Reneo Pharmaceuticals (RPHM)
| -88.7 | -87.3 | -88.0 | -97.4 | -70.7 | -- | -- |
|
BSE Sensex*
| -10.9 | -4.9 | -8.9 | -7.6 | 6.9 | 8.3 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
|---|---|---|
|
Reneo Pharmaceuticals (RPHM)
| -31.3 | -72.7 |
|
S&P Small-Cap 600
| 13.9 | -17.4 |
|
BSE Sensex
| 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Reneo Pharmaceuticals (RPHM)
|
1.8 | 60.8 | 1.5 | -56.5 | -4,286.6 | -68.3 | -- | 0.8 |
| 0.0 | 0.7 | 1.0 | -84.3 | -917.2 | -- | -- | 0.0 |
Shareholding Pattern
View DetailsAbout Reneo Pharmaceuticals (RPHM)
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company's lead product candidate is REN001, a potent and... selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California. Read more
-
Founder & Executive Chairman
Mr. Michael G. Grey
-
Founder & Executive Chairman
Mr. Michael G. Grey
-
Headquarters
Irvine, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Reneo Pharmaceuticals (RPHM)
What is the current share price of Reneo Pharmaceuticals Inc (RPHM) Today?
The share price of Reneo Pharmaceuticals Inc (RPHM) is $1.81 (NASDAQ) as of 04-Oct-2024 18:32 EDT. Reneo Pharmaceuticals Inc (RPHM) has given a return of -70.72% in the last 3 years.
What is the current PB & PE ratio of Reneo Pharmaceuticals Inc (RPHM)?
Since, TTM earnings of Reneo Pharmaceuticals Inc (RPHM) is negative, P/E ratio is not available.
The P/B ratio of Reneo Pharmaceuticals Inc (RPHM) is 0.79 times as on 04-Oct-2024, a 81 discount to its peers’ median range of 4.08 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
What is the 52 Week High and Low of Reneo Pharmaceuticals Inc (RPHM)?
The 52-week high and low of Reneo Pharmaceuticals Inc (RPHM) are Rs -- and Rs -- as of 24-May-2026.
What is the market cap of Reneo Pharmaceuticals Inc (RPHM)?
Reneo Pharmaceuticals Inc (RPHM) has a market capitalisation of $ 61 Mln as on 04-Oct-2024. As per SEBI classification, it is a Small Cap company.
Should I invest in Reneo Pharmaceuticals Inc (RPHM)?
Before investing in Reneo Pharmaceuticals Inc (RPHM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.